Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06217068 · ClinicalTrials.gov registry record · Phase 1

Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity

A Phase 1 study, sponsored by University of Georgia.

Completed
Registry status
Phase 1
Development phase
9
Enrollment target

NCT06217068: Completed Phase 1 study, sponsored by University of Georgia.

NCT06217068 is a Phase 1 study that has completed, run by University of Georgia. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06217068, a Phase 1 study, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
Phase 1
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to understand how college students' biomarkers change with a relatively short bout of moderate-intensity physical activity. The investigators are comparing biomarkers in between self-reported physically active and sedentary students in terms of their percent difference and change. The investigators are also studying physically active versus sedentary college students' mental health. This is a mentored student research project in the investigator's lab (not part of a thesis, dissertation, or other coursework requirements), where multiple students have developed research questions using the same study design.

Primary Outcome

Blood sample

Interventions

  • BEHAVIORAL Elliptical Activity

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2024-03-11
Est. Completion 2025-02-07
Phase Phase 1
University of Georgia

59 total trials

What the finished NCT06217068 record still lists

NCT06217068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Elliptical Activity is the first listed.

NCT06217068 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06217068 about?

NCT06217068 is a clinical study titled "Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity". The purpose of this study is to understand how college students' biomarkers change with a relatively short bout of moderate-intensity physical activity. The investigators are comparing biomarkers in between self-reported physically active and sedentary students in terms of their percent difference a...

What is the current status of trial NCT06217068?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2024-03-11. Estimated completion is 2025-02-07.

What interventions are being tested in trial NCT06217068?

The interventions under investigation include: Elliptical Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT06217068?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06217068's enrollment target sits among peer trials

9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06217068, the US trial registry maintained by the National Library of Medicine. NCT06217068 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.